168 related articles for article (PubMed ID: 9329389)
1. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.
Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
Surgery; 1998 Dec; 124(6):1094-8; discussion 1098-9. PubMed ID: 9854589
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
5. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
6. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas.
Garner SC; Hinson TK; McCarty KS; Leight M; Leight GS; Quarles LD
Surgery; 1997 Dec; 122(6):1166-75. PubMed ID: 9426434
[TBL] [Abstract][Full Text] [Related]
9. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
[TBL] [Abstract][Full Text] [Related]
10. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
11. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.
Cetani F; Pinchera A; Pardi E; Cianferotti L; Vignali E; Picone A; Miccoli P; Viacava P; Marcocci C
J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus.
Thompson DB; Samowitz WS; Odelberg S; Davis RK; Szabo J; Heath H
J Clin Endocrinol Metab; 1995 Nov; 80(11):3377-80. PubMed ID: 7593455
[TBL] [Abstract][Full Text] [Related]
13. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
[TBL] [Abstract][Full Text] [Related]
14. Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3.
Rogers KV; Dunn CK; Conklin RL; Hadfield S; Petty BA; Brown EM; Hebert SC; Nemeth EF; Fox J
Endocrinology; 1995 Feb; 136(2):499-504. PubMed ID: 7835282
[TBL] [Abstract][Full Text] [Related]
15. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor.
Szabo E; Carling T; Hessman O; Rastad J
J Clin Endocrinol Metab; 2002 Aug; 87(8):3961-5. PubMed ID: 12161540
[TBL] [Abstract][Full Text] [Related]
17. Abnormal calcium distribution in human parathyroid adenomas as possible cause of primary hyperparathyroidism.
Dietel M; Arps H; Niendorf A; Schäfer HJ; Hölzel F
Horm Metab Res; 1987 Apr; 19(4):177-81. PubMed ID: 3583224
[TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma.
Kaneko C; Mizunashi K; Tanaka M; Uzuki M; Kikuchi M; Sawai T; Goto MM
Calcif Tissue Int; 1999 Mar; 64(3):271-2. PubMed ID: 10024390
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.
Lu M; Berglund E; Larsson C; Höög A; Farnebo LO; Bränström R
J Endocrinol; 2011 Jan; 208(1):31-9. PubMed ID: 20974637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
